17.12
Dose Response Curve: Conventional Versus Nonmonotonic
The correlation between a drug's dosage and its impact on a biological system is a cornerstone of pharmacology and toxicology. Conventional dose–respo…
Conventional dose-response curves are sigmoidal, including individual graded and population-wide quantal relationships.
The quantal dose–response curves for the therapeutic effect and lethality show ED50 and LD50, respectively, together generating the therapeutic index, TI.
Drugs with high TI are generally safe unless the patient is allergic. However, lower TI drugs should be used cautiously.
Alternatively, comparing the ED99 and LD1 yields a margin of safety.
Nonmonotonic dose-response curves can be U-shaped, hockey stick-shaped, and inverted U-shaped.
The U-shaped curve’s bottom represents the optimal dose achieving homeostasis, with overdose toxicity and increased death risk above it.
Toxicants can saturate detoxifying mechanisms, leading to an initial no-response followed by a sharp rise in an adverse response, displaying a hockey stick-shaped plot.
Prolonged drug exposure desensitizes receptors, showing an initial rise to maximal response, followed by a decline at extremely high levels, forming an inverted U-shaped curve.
View the full transcript and gain access to JoVE Core videos
Q1: What is the therapeutic index and why does it matter for drug safety?
The therapeutic index (TI) is the ratio of the lethal dose (LD50) to the effective therapeutic dose (ED50). A higher TI indicates a safer drug with a wider margin between therapeutic benefit and toxicity. Drugs with high TI are generally safe unless the patient has allergic reactions, while lower TI drugs require cautious use and careful monitoring.
Q2: How do conventional dose-response curves differ from nonmonotonic curves?
Conventional dose-response curves are sigmoidal, showing a proportional increase in response as dose increases. Nonmonotonic curves deviate from this pattern, displaying U-shaped, hockey stick-shaped, or inverted U-shaped relationships. These complex patterns reflect biological mechanisms like receptor desensitization, saturation of detoxifying enzymes, or essential nutrient deficiencies at low doses.
Q3: What does a U-shaped dose-response curve indicate about drug effects?
A U-shaped curve shows an optimal dose that achieves homeostasis at its lowest point. Below this dose, deficiency effects occur; above it, toxicity and increased death risk emerge. This pattern is common with essential metals and vitamins, where both insufficient and excessive amounts harm the biological system.
Q4: Why do some toxicants produce a hockey stick-shaped dose-response curve?
Toxicants like formaldehyde can saturate the body's detoxifying mechanisms, initially producing no observable response. Once detoxification capacity is exceeded, adverse effects rise sharply, creating the characteristic hockey stick shape. This threshold effect demonstrates how protective biological systems can mask toxicity until overwhelmed.
Q5: What causes an inverted U-shaped dose-response curve?
Prolonged drug exposure can desensitize receptors, causing an inverted U-shaped curve. The response initially rises to a maximum, then declines at extremely high doses due to receptor downregulation. This pattern occurs with certain hormonal therapies and demonstrates how excessive drug exposure paradoxically reduces efficacy.
Q6: How does the margin of safety differ from the therapeutic index?
The margin of safety uses ED99 and LD1 values instead of ED50 and LD50, providing protection for the most vulnerable individuals. While the therapeutic index measures central tendency, the margin of safety accounts for population extremes, ensuring safer drug use across diverse patient populations.
Q7: Why is understanding nonmonotonic dose-response relationships important in toxicology?
Nonmonotonic relationships reveal that dose-response biology is complex and context-dependent. Recognizing U-shaped, hockey stick-shaped, and inverted U-shaped patterns is crucial for accurately evaluating drug efficacy and safety. These diverse relationships underscore why comprehensive dose assessment across multiple levels is essential for proper drug evaluation.